Evaluating Fertitonex for improving semen quality in varicocele patients
Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient, Placebo Controlled Study
This study is testing if Fertitonex can improve sperm quality in men with varicocele and infertility compared to a placebo.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 110 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Menoufia University Academic / other |
| Locations | 1 site (Shebin El-Kom, Menoufia) |
| Trial ID | NCT06718426 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effects of Fertitonex on semen parameters in men diagnosed with clinical varicocele and primary infertility. Varicocele is a common condition that can contribute to male infertility, often characterized by abnormal semen analysis results. The study will involve administering Fertitonex capsules to participants and comparing the outcomes with a placebo group. The goal is to determine whether Fertitonex can improve sperm quality by reducing oxidative stress and enhancing semen parameters.
Who should consider this trial
Good fit: Ideal candidates for this study are men experiencing primary infertility with abnormal semen analysis and clinically evident varicocele.
Not a fit: Patients with secondary infertility, normal semen analysis, or those who have undergone varicocelectomy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for men with varicocele-related infertility.
How similar studies have performed: While there have been studies on antioxidants for improving sperm quality, the specific use of Fertitonex in this context is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary infertility. * Abnormal semen analysis parameters. * Clinically evident varicocele confirmed by scrotal duplex. Exclusion Criteria: * 2ry infertility. * Normal semen analysis parameters. * Clinically non-evident varicocele. * Past history of varicocelectomy.
Where this trial is running
Shebin El-Kom, Menoufia
- Menoufia Faculty of Medicine — Shebin El-Kom, Menoufia, Egypt (Recruiting)
Study contacts
- Study coordinator: Ammar F Alorabi
- Email: ammar.alorabi95@gmail.com
- Phone: +201067608011
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.